The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >Revolutionary Bioinformatics solution providing fast and
accurate, client-specific analysis services.
Trust CAS with your BI analysis !
Celemics offers easy-to-use kit with all components needed from RNA fragmentation to double-stranded cDNA synthesis suitable for NGS.
View Detail >Celemics exclusive enzymes and buffers for enhanced hybridization to ensure improved coverage and uniformity.
View Detail >Proven market-leading purification and size selection efficiency supported by Celemics’ unique magnetic bead-based chemistry. Compatible with all Celemics’ panels as well as other NGS providers
View Detail >High-quality streptavidin bead that selectively isolates biotinylated ligands bound to hybridization probes; minimizing DNA loss during the target enrichment process.
View Detail >CeleNM™ Bead streamlines library quantification and normalization in Next-Generation Sequencing (NGS). Say goodbye to traditional QC processes, saving time and costs while ensuring robust results. Experience uniform sequencing data distribution and comparable on-target ratios with CeleNM™ Bead.
View Detail >Celemics’ highly optimized polymerase ensures market-leading amplification efficiency and accuracy with minimized PCR bias and error rate.
View Detail >Highly optimized library preparation kit to be used with all Celemics ready-to-use or customized panels. Experience the incomparable efficiency and performance for NGS library preparation
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Celemics’ comprehensive NGS panel for somatic cancer allows highly accurate and comprehensive analysis for identifying significant mutations and variants for solid tumors.
Celemics’ comprehensive NGS panel for somatic cancer allows highly accurate and comprehensive analysis for identifying significant mutations and variants for solid tumors.
Celemics has developed NGS ctDNA-based kits for colon, breast, and lung cancer assays. We have integrated our market-leading proprietary technologies and thoroughly validated and optimized as ready-to-use panels for clinical diagnostics.
Celemics offers end-to-end NGS-based detection and discovery solutions for Biopharma, CRO, and Drug discovery research fields.
In order to overcome the limitations of analyzing clinical diseases with conventional whole exome sequencing, Celemics introduces NGS-based clinical diagnostic solution for efficient detection of disease-causing variants for inherited diseases.
Celemics offers flexible choice of assessing extensive target regions associated with Pharmacogenomics for client-specific drug prescription and drug metabolism.
Celemics’ virus panels are designed to detect and identify disease-causing viruses. With our exclusive technologies, we provide efficient and accurate detection of targeted virus trains as well as procurement of credible data for whole viral genome sequencing.
To fulfill the expectations and growing needs for sequencing animals and plants, Celemics offers range of ready-to-use applicable to agrigenomics field as well as an option for developing customized NGS panel to specifically fit individual research purposes.
With Celemics’ proprietary technologies for assay development and optimization, we offer complete and robust NGS solutions for transcriptome, fusion, and isoform analyses for various sample types and conditions.
Celemics provides comprehensive solution for DNA methylation sequencing with proprietary probes specifically designed for methyl-seq, enabling accurate detection of methylation sites.
Complete solution with flexible panel design for characterization and differentiation of a myriad of microbial species.
Accurate and efficient analysis of IGH population that can detect MRD as low as 10-6 with optimized primers that can minimize sequencing loss and PCR duplications.
Celemics introduces revolutionary BI solution aiming to provide client-specific service. We provide fast, accurate, and sophisticated analyses of your NGS data accompanied by our proprietary bioinformatics pipeline.
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >Utilizing NGS-based target enrichment methods for higher genotyping efficiency and accuracy. Providing cost-effective and optimized experiment compared to conventional methods, such as GBS, PCR and microarray in plant and animal research
View Detail >
Revolutionary Bioinformatics solution providing fast and
accurate, client-specific analysis services.
Trust CAS with your BI analysis
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >In-silico designed and wet-lab validated exclusive probes to ensure state-of-the-art capture performance
View Detail >Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >Let’s change the NGS market together – our global presence and partners world-wide
View Detail >Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >CELEMICS는 다양한 NGS 플랫폼에 최적화된 키트를 제공하여, 고객들이 서로 다른 시퀀싱 시스템에서도 원활하게 연구를 진행할 수 있도록 지원합니다. 이번 게시글에서는 CELEMICS의 키트가 Singular Genomics NGS 플랫폼에 어떻게 맞춤화될 수 있는지 소개합니다.
워크플로우(Workflow)
먼저, Illumina 플랫폼용으로 준비된 NGS 라이브러리를 Singular Genomics 플랫폼에서 사용할 수 있도록 전환하는 방법을 살펴보겠습니다.
전환 과정은 기존 CELEMICS의 Illumina 라이브러리 준비 및 타겟 농축(Target Enrichment) 키트 워크플로우와 동일하게 진행됩니다. 즉, 이미 CELEMICS 제품을 사용 중인 고객이라면 실험 절차를 수정하지 않고도 Singular Genomics NGS 플랫폼으로 손쉽게 전환할 수 있습니다.
결과(Results)
CELEMICS의 전환(Conversion) 전략을 통해 처리된 라이브러리와 Illumina에서 준비된 Native Library를 비교하여 성능을 평가했습니다.
No. | Library Preparation | Post-PCR Primer Set | Conc.(ng/uL) |
---|---|---|---|
1 | Illumina Preparation | Illumina Native | 5.05 |
2 | 8.8 | ||
3 | Singular UDI-Primer | 6.54 | |
4 | 9.76 |
Experiment Condition: Hybridization with 500 ng library. Panel size over 1 Mbp, Post-PCR 14 Cycles
타겟 농축(Target Enrichment) 및 Post-PCR 또는 Conversion PCR을 수행한 후, 두 플랫폼에서 비교적 동등한 실험 결과를 확인할 수 있습니다. 이후, 셀레믹스의 바이오인포매틱스 파이프라인(Bioinformatics Pipeline)을 통해 Primary Analysis를 수행한 비교 분석을 진행했습니다.
| On-Target Ratio
| Duplication Ratio
| Fold 80 Base Penalty
| Uncovered Region
Duplication Ratio, On-Target Ratio, Fold 80 Base Penalty, Percentage of Uncovered Regions등의 지표에서 Illumina와 Singular 플랫폼 간 유의미한 차이가 없음을 확인했습니다.
이 결과는 CELEMICS의 Singular Genomics 플랫폼 Kit는기존 셀레믹스의 Illumina 플랫폼 키트와 동일한 Library Preparation kit와 Target enrichment 과정이 동일하며, Illumina 플랫폼에서 얻어진 것과 동일한 수준의 높은 품질의 시퀀싱 결과를 제공한다는 것을 입증합니다.
CELEMICS는 Singular Genomics 외에도 MGI, Element Biosciences, PacBio Onso 플랫폼에 대한 라이브러리 전환 키트(Library Conversion Kit)를 제공합니다.